These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9580890)
1. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. Remarque EJ; de Bruijn IA; Boersma WJ; Masurel N; Ligthart GJ J Med Virol; 1998 May; 55(1):82-7. PubMed ID: 9580890 [TBL] [Abstract][Full Text] [Related]
2. Cross-reaction but no avidity change of the serum antibody response after influenza vaccination. Brokstad KA; Cox RJ; Major D; Wood JM; Haaheim LR Vaccine; 1995 Nov; 13(16):1522-8. PubMed ID: 8578836 [TBL] [Abstract][Full Text] [Related]
3. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803 [TBL] [Abstract][Full Text] [Related]
5. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients. Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967 [TBL] [Abstract][Full Text] [Related]
6. Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift. Pyhälä R; Kinnunen L; Kumpulainen V; Ikonen N; Kleemola M; Cantell K Vaccine; 1993; 11(10):1013-7. PubMed ID: 8212820 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Remarque EJ; de Jong JM; van der Klis RJ; Masurel N; Ligthart GJ Exp Gerontol; 1999 Jan; 34(1):109-15. PubMed ID: 10197732 [TBL] [Abstract][Full Text] [Related]
8. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601 [TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638 [TBL] [Abstract][Full Text] [Related]
10. The relationship between influenza vaccine-induced specific antibody responses and vaccine-induced nonspecific autoantibody responses in healthy older women. Huang YP; Gauthey L; Michel M; Loreto M; Paccaud M; Pechere JC; Michel JP J Gerontol; 1992 Mar; 47(2):M50-5. PubMed ID: 1538066 [TBL] [Abstract][Full Text] [Related]
11. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855 [TBL] [Abstract][Full Text] [Related]
12. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children. Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451 [TBL] [Abstract][Full Text] [Related]
13. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. Grund S; Adams O; Wählisch S; Schweiger B J Virol Methods; 2011 Feb; 171(2):369-73. PubMed ID: 21146560 [TBL] [Abstract][Full Text] [Related]
15. Possible correlation between low antigenic drift of A(H1N1) influenza viruses and induction of HI antibodies. Iorio AM; Zei T; Neri M; Alatri A Eur J Epidemiol; 1996 Dec; 12(6):589-94. PubMed ID: 8982618 [TBL] [Abstract][Full Text] [Related]
16. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Powers DC; Hanscome PJ; Pietrobon PJ Vaccine; 1995 Oct; 13(14):1330-5. PubMed ID: 8585289 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of the antibody response to seasonal influenza vaccination among the elderly. Kositanont U; Assantachai P; Wasi C; Puthavathana P; Praditsuwan R Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793 [TBL] [Abstract][Full Text] [Related]
18. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1. Zhang R; Rong X; Pan W; Peng T Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624 [TBL] [Abstract][Full Text] [Related]
19. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. Glathe H; Bigl S; Grosche A Vaccine; 1993; 11(7):702-5. PubMed ID: 8342318 [TBL] [Abstract][Full Text] [Related]
20. Comparison of a commercial H1N1 enzyme-linked immunosorbent assay and hemagglutination inhibition test in detecting serum antibody against swine influenza viruses. Yoon KJ; Janke BH; Swalla RW; Erickson G J Vet Diagn Invest; 2004 May; 16(3):197-201. PubMed ID: 15152833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]